Dedicated breast MRI systems offer significant improvement in performance and diagnostic accuracy.
Dedicated breast MRI systems offer significant improvement in performance and diagnostic accuracy, said researchers in a study published in the October issue of the journal Radiology.
Researchers assessed the sensitivity and specificity of images of 934 patients (347 screening exams and 587 diagnostic exams) from April 2006 to December 2007. The women were between the ages of 25 and 89. The images were taken by Aurora Imaging Technology Inc.’s dedicated 1.5-T breast MR system that used high-spatial-resolution, high-contrast-resolution spiral trajectory acquisitions.
Results showed sensitivity for the dedicated MRI system of 92 percent (92 women out of 100) and specificity of 88.9 percent (741 women out of 834). The negative predictive value for screening cases was 100 percent. The area under the receiver operating characteristics (ROC) curve was 94 percent. The false-positive rate was 93 of 834 (11.2 percent) for all cases, but only 16 of 326 (4.9 percent) for the screening cohort.
“False positive rates from previously reported trials using whole-body breast MRI have typically been between 30 and 50 percent,” study investigator Alan Hollingsworth, MD, said in a release. Hollingsworth is the medical director and a breast surgeon at Mercy Women’s Center at Mercy Health Center.
“These studies have led to criticism of breast MRI for its high false positive rates, resulting in unnecessary biopsies, surgical procedures and anxiety for the patient,” he said. “The dedicated breast MRI system offers a significant improvement in performance. Even with 93 false positives, 25 (27 percent) were high-risk histologies for which excision is often recommended. This kind of performance should provide breast radiologists and surgeons alike a higher level of diagnostic confidence and could have significant impact on the role of breast MRI.”
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.